Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms

American Journal of Rhinology and Allergy

Volumn 27, Issue 1, 2013, Pages 48-53

  Baroody, Fuad M ^a   Logothetis, Hercules ^a   Vishwanath, Shilpa ^a   Bashir, Mohamad ^a   De Tineo, Marcella ^a   Naclerio, Robert M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; FLUTICASONE FUROATE; HISTAMINE; OLOPATADINE; PLACEBO; TRYPTASE;

ADOLESCENT; ALLERGY TEST; ARTICLE; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; CORNEA REFLEX; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EOSINOPHIL; EPIPHORA; FEMALE; HAY FEVER; HISTAMINE RELEASE; HUMAN; MALE; MAST CELL; NASAL LAVAGE; NASAL OCULAR REFLEX; NASAL PRURITUS; NOSE OBSTRUCTION; OCULAR PRURITUS; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SNEEZING; THROAT IRRITATION; TREATMENT RESPONSE;

ADMINISTRATION, INTRANASAL; ADULT; ALLERGENS; ANDROSTADIENES; CROSS-OVER STUDIES; DIBENZOXEPINS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; EOSINOPHILS; EYE; FEMALE; HISTAMINE; HUMANS; INJECTIONS, INTRAOCULAR; MALE; MIDDLE AGED; NOSE; REFLEX; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 84876034399     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3841     Document Type: Article

References (18)

1. Baroody FM. Allergic rhinitis: Broader disease effects and implications for management. Otolaryngol Head Neck Surg 128:616-631, 2003.
2. Goetzel RZ, Long SR, Ozminkowski RJ, et al. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med 46:398-412, 2004.
3. Wallace DV, Dykewicz MS, Bernstein DI, et al.; Joint Task Force on Practice; American Academy of Allergy; Asthma and Immunology; American College of Allergy; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 122(suppl):S1-S84, 2008.
4. Wuthrich B, Brignoli R, Canevascini M, and Gerber M. Epidemiological survey in hayfever patients: Symptom prevalence and severity and influence on patient management. Schweiz Med Wochenschr 128:139-143, 1998.
5. Allergies in America: A landmark survey of nasal allergy sufferers: Executive summary. Available at online at www.myallergiesinamerica. com; accessed July, 2008.
6. Noon L. Prophylactic inoculation against hay fever. Lancet 1:1572- 1573, 1911.
7. Baroody FM, Foster KA, Markaryan A, et al. Nasal-ocular reflexes contribute to eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol 100:194-199, 2008.
8. Baroody FM, Shenaq D, DeTineo M, et al. Fluticasone furoate nasal spray reduces the nasal ocular reflex: A Mechanism to explain the effectiveness of intranasal steroids in controlling eye symptoms in allergic rhinitis. J Allergy Clin Immunol 123:1342-1348, 2009.
9. Ustinova EE, Fraser MO, and Pezzone1 MA. Cross-talk and sensitization of bladder afferent nerves. Neurourol Urodyn 29:77-81, 2010.
10. Majchel AM, Baroody F, Kagey-Sobotka A, et al. Effect of oxymetazoline on the early response to nasal challenge with antigen. J Allergy Clin Immunol 92:767-770, 1993.
11. Bascom R, Wachs M, Naclerio RM, et al. Basophil influx occurs after nasal antigen challenge: Effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 81:580-589, 1988.
12. Iliopoulos O, Baroody FM, Naclerio RM, et al. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 148:2223-2228, 1992.
13. Gendi SG, and Wolff AH. Effect of nasal olopatadine on histamine skin prick reactivity. J Allergy Clin Immunol 127:AB255, 2011 (Abs).
14. Jones JD, Temino VM, Dworski R, et al. Use of olopatadine ophthalmic solution and reactivity of histamine skin testing. Allergy Asthma Proc 29:636-639, 2008.
15. Leonardi A, and Quintieri L. Olopatadine: A drug for allergic conjunctivitis targeting the mast cell. Expert Opin Pharmacother 11:969- 981, 2010.
16. Bielory L. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate. Ann Allergy Asthma Immunol 100:272-279, 2008.
17. Naclerio RM. Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis. Otolaryngol Head Neck Surg 138:129- 139, 2008.
18. O'Meara TJ, Sercombe JK, Morgan G, et al. The reduction of rhinitis symptoms by nasal filters during natural exposure to ragweed and grass pollen. Allergy 60:529-532, 2005.